RxDoctor Payments Data

David Davis, MD

Family Medicine · Youngstown, OHNPI 1982678272

Payments from drug & device makers

$3,375in general payments, 2019–2025

Across 176 payments — averaging $19.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$649
  • Johnson & Johnson$547
  • Boehringer Ingelheim$326
  • Pfizer$317
  • Biohaven Pharmaceuticals, Inc.$292
  • Biohaven Pharmaceutical Holding Company Ltd.$264
  • plus $980 from 16 others

What the payments were for

  • Food & beverage$3,375100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,375 in reported general payments places this provider in the 80th percentile of 3,983 family medicine providers in Ohio.

See all family medicine providers in Ohio

Medicare billing

Part B allowed, 2024
$14,325
Medicare patients
42
Services billed
268

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban57$57,606
JardianceEmpagliflozin66$53,400
OzempicSemaglutide28$32,817
Bydureon BciseExenatide Microspheres17$16,650
CreonLipase/Protease/Amylase18$14,609
JanuviaSitagliptin Phosphate16$13,276
Potassium Chloride165$3,224
Clonidine13$2,826
Atorvastatin Calcium255$2,620
Valsartan-HydrochlorothiazideValsartan/Hydrochlorothiazide76$2,191
Metoprolol Succinate139$1,867
Albuterol Sulfate HfaAlbuterol Sulfate74$1,741
Amlodipine Besylate322$1,695
Valsartan52$1,658
Diltiazem 24hr Er (Cd)Diltiazem Hcl24$1,602

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$317$57,60657 claims
Boehringer IngelheimJardiance$326$53,40066 claims
Novo NordiskOzempic$11$32,81728 claims
AbbVieCreon$649$14,60918 claims
MerckJanuvia$76$13,27616 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 3,983 family medicine providers in Ohio.

Other family medicine in Youngstown

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →